BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
BD (NYSE: BDX) has appointed Bilal Muhsin as Executive Vice President and future President of its Connected Care segment, effective July 2, 2025. Muhsin, who will report to CEO Tom Polen, joins from Masimo where he served as COO during his 25-year tenure.
In this newly created role, Muhsin will lead BD's Connected Care strategy, focusing on advanced analytics and AI solutions alongside smart devices to enhance patient care efficiency. The appointment aligns with BD's transformation into a pure-play MedTech leader, emphasizing connected medication management, advanced workflow robotics, and smart monitoring solutions.
Muhsin brings significant expertise in medical engineering and software development, holding over 50 patents in Medical Systems Communication, Analytics, and Patient Monitoring Systems.
BD (NYSE: BDX) ha nominato Bilal Muhsin Vice Presidente Esecutivo e futuro Presidente del segmento Connected Care, a partire dal 2 luglio 2025. Muhsin, che riporter脿 direttamente al CEO Tom Polen, arriva da Masimo dove ha ricoperto il ruolo di COO durante i suoi 25 anni di carriera.
In questo nuovo ruolo, Muhsin guider脿 la strategia di BD nel settore Connected Care, concentrandosi su soluzioni avanzate di analisi e intelligenza artificiale insieme a dispositivi smart per migliorare l'efficienza nell'assistenza ai pazienti. La nomina 猫 in linea con la trasformazione di BD in un leader MedTech puro, con un focus sulla gestione connessa dei farmaci, robotica avanzata per i flussi di lavoro e soluzioni di monitoraggio intelligenti.
Muhsin porta con s茅 una notevole esperienza nell'ingegneria medica e nello sviluppo software, detenendo oltre 50 brevetti nei campi della comunicazione nei sistemi medici, analisi e sistemi di monitoraggio dei pazienti.
BD (NYSE: BDX) ha nombrado a Bilal Muhsin como Vicepresidente Ejecutivo y futuro Presidente de su segmento Connected Care, con efecto a partir del 2 de julio de 2025. Muhsin, quien reportar谩 al CEO Tom Polen, proviene de Masimo, donde se desempe帽贸 como COO durante sus 25 a帽os de carrera.
En este nuevo puesto, Muhsin liderar谩 la estrategia de Connected Care de BD, enfoc谩ndose en soluciones avanzadas de an谩lisis y IA junto con dispositivos inteligentes para mejorar la eficiencia en la atenci贸n al paciente. Este nombramiento est谩 alineado con la transformaci贸n de BD en un l铆der MedTech puro, con 茅nfasis en la gesti贸n conectada de medicamentos, rob贸tica avanzada para flujos de trabajo y soluciones inteligentes de monitoreo.
Muhsin aporta una amplia experiencia en ingenier铆a m茅dica y desarrollo de software, con m谩s de 50 patentes en comunicaci贸n de sistemas m茅dicos, an谩lisis y sistemas de monitoreo de pacientes.
BD (NYSE: BDX)電� 2025雲� 7鞗� 2鞚茧秬搿� 牍岆瀯 氍挫嫚鞚� Connected Care 攵�氍胳潣 斓滉碃鞖挫榿毂呾瀯鞛� 瓴� 氙鸽灅 靷灔鞙茧 鞛勲獏頄堨姷雼堧嫟. 氍挫嫚鞚� CEO 韱� 韽措爩鞐愱矊 氤搓碃頃橂┌, 25雲勱皠 攴茧頃� 毵堨嫓氇棎靹� COO搿� 鞚柬暅 瓴诫牓鞚� 鞛堨姷雼堧嫟.
靸堧 鞁犾劋霅� 鞚� 歆侅眳鞐愳劀 氍挫嫚鞚� BD鞚� Connected Care 鞝勲灥鞚� 鞚措亴氅�, 頇橃瀽 旃橂 須湪靹膘潉 雴掛澊旮� 鞙勴暣 瓿犼笁 攵勳劃 氚� AI 靻旊（靺�瓿� 鞀る韸� 旮瓣赴鞐� 欷戩爯鞚� 霊� 鞓堨爼鞛呺媹雼�. 鞚� 鞛勲獏鞚� BD臧� 靾滌垬 MedTech 毽崝搿� 氤�氇晿電� 瓿检爼鞐愳劀 鞐瓣舶霅� 鞎诫 甏�毽�, 觳嫧 鞛戩梾 頋愲 搿滊磭 瓿淀暀, 鞀る韸� 氇媹韯半 靻旊（靺橃棎 歆戩頃橂姅 鞝勲灥瓿� 鞚检箻頃╇媹雼�.
氍挫嫚鞚� 鞚橂 瓿淀暀 氚� 靻岉攧韸胳洦鞏� 臧滊皽 攵勳暭鞐愳劀 頀嶋秬頃� 鞝勲靹膘潉 臧栰稊瓿� 鞛堨溂氅�, 鞚橂 鞁滌姢韰� 韱奠嫚, 攵勳劃 氚� 頇橃瀽 氇媹韯半 鞁滌姢韰� 攵勳暭鞐愳劀 50臧� 鞚挫儊鞚� 韸鬼棃毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
BD (NYSE : BDX) a nomm茅 Bilal Muhsin Vice-Pr茅sident Ex茅cutif et futur Pr茅sident de sa division Connected Care, 脿 compter du 2 juillet 2025. Muhsin, qui reportera au CEO Tom Polen, rejoint l'entreprise apr猫s avoir 茅t茅 COO chez Masimo durant ses 25 ann茅es de carri猫re.
Dans ce nouveau r么le cr茅茅 pour lui, Muhsin dirigera la strat茅gie Connected Care de BD, en se concentrant sur les solutions avanc茅es d'analytique et d'IA ainsi que sur les dispositifs intelligents pour am茅liorer l'efficacit茅 des soins aux patients. Cette nomination s'inscrit dans la transformation de BD en un leader MedTech pur, mettant l'accent sur la gestion connect茅e des m茅dicaments, la robotique avanc茅e des flux de travail et les solutions de surveillance intelligentes.
Muhsin apporte une expertise significative en ing茅nierie m茅dicale et d茅veloppement logiciel, d茅tenant plus de 50 brevets dans les domaines de la communication des syst猫mes m茅dicaux, de l'analytique et des syst猫mes de surveillance des patients.
BD (NYSE: BDX) hat Bilal Muhsin zum Executive Vice President und zuk眉nftigen Pr盲sidenten seines Connected Care-Segments ernannt, wirksam ab dem 2. Juli 2025. Muhsin, der direkt an CEO Tom Polen berichten wird, kommt von Masimo, wo er w盲hrend seiner 25-j盲hrigen T盲tigkeit als COO t盲tig war.
In dieser neu geschaffenen Position wird Muhsin die Connected Care-Strategie von BD leiten, mit Fokus auf fortschrittliche Analytik- und KI-L枚sungen sowie intelligente Ger盲te, um die Effizienz der Patientenversorgung zu verbessern. Die Ernennung steht im Einklang mit BD's Transformation zu einem reinen MedTech-F眉hrer, mit Schwerpunkt auf vernetztem Medikamentenmanagement, fortschrittlicher Workflow-Robotik und intelligenten 脺berwachungsl枚sungen.
Muhsin bringt umfangreiche Expertise in medizinischer Technik und Softwareentwicklung mit und h盲lt 眉ber 50 Patente in den Bereichen medizinische Systemkommunikation, Analytik und Patienten眉berwachungssysteme.
- Strategic appointment of experienced executive with 25 years in healthcare technology
- Focus on AI and advanced analytics positions BD for digital healthcare transformation
- Appointment supports BD's strategic transition to pure-play MedTech leadership
- New leader brings strong innovation credentials with over 50 patents
- None.
Under Bilal's leadership, BD Connected Care will aim to leverage advanced analytics and AI solutions alongside BD's industry-leading smart devices to improve the efficiency and effectiveness of patient care while driving compelling growth opportunities in new areas of health care, such as connected medication management, advanced workflow robotics and smart monitoring solutions. In this newly created role, Muhsin will be responsible for advancing BD's future Connected Care strategy, including shaping organizational capabilities, driving and executing the commercial strategy, accelerating industry-leading innovation initiatives, and ensuring operational and quality excellence.
"With his extensive and deep knowledge of connected care technologies, software and informatics strategies, combined with his intense focus on the customer, Bilal will have a profound impact at BD as we advance our connected care strategy with cutting-edge, AI-driven technology that transforms patient care by improving safety, efficiency and outcomes," said Polen. "This is another step forward in advancing our New BD strategy as a differentiated, pure-play MedTech leader, and Bilal will play a critical role in helping BD accelerate our growth and impact on healthcare by capitalizing on the significant digital, robotic and AI technology innovation that we are so well-positioned to capitalize on."听 听
Muhsin joins BD from Masimo, a health technology and consumer electronics manufacturer, where he spent 25 years, most recently听as chief operating officer. Prior to that, Bilal held several other leadership roles at Masimo, including executive vice president of engineering, marketing and regulatory. Muhsin has decades of experience with a proven track record in medical engineering and software development, and holds more than 50 patents in Medical Systems Communication, Analytics and Patient Monitoring Systems.
Muhsin holds a Bachelor of Science听degree in Computer Science from San Diego State University.
About BD听
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at , X (formerly Twitter) or Instagram .听听
Contacts: | |
Media: | Investors: |
Fallon McLoughlin | Adam Reiffe |
BD Corporate Communications | BD Investor Relations |
201.258.0361 | 201.847.6927 |
听
View original content to download multimedia:
SOURCE BD (Becton, Dickinson and Company)
FAQ
Who is the new Connected Care segment president at BD (BDX)?
What is Bilal Muhsin's background before joining BD (BDX)?
What will be Bilal Muhsin's responsibilities at BD (BDX)?
How does this appointment align with BD's (BDX) strategy?
Who will Bilal Muhsin report to at BD (BDX)?
